Decoy Therapeutics Inc. (DCOY) Total liabilities 2016–2022
Decoy Therapeutics Inc. (DCOY) total liabilities at each fiscal year-end, per SEC filings.
$4.3MFY2022 · since FY2016: $3.9M → $4.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $4.3M | +102.1% |
| FY2021 | $2.1M | -23.9% |
| FY2020 | $2.8M | -16.3% |
| FY2019 | $3.3M | -58.0% |
| FY2018 | $7.9M | +33.9% |
| FY2017 | $5.9M | +51.0% |
| FY2016 | $3.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice